Fig. 3. Comparison of death-censored graft survival rate among DSA (–)+treatment (–), DSA (–)+treatment (+), DSA (+)+treatment (–), and DSA (+)+treatment (+). dnDSA, de novo donor-specific antibody.

Korean J Transplant 2021;35:33~40 https://doi.org/10.4285/kjt.20.0052

© Korean Journal of Transplantation